Fetal fibronectin as a predictor of spontaneous preterm birth: A European perspective

Manju Chandiramani*, Gian C. Di Renzo, Elisabeth Gottschalk, Hanns Helmer, Wolfgang Henrich, Irene Hoesli, Ben Mol, Jane E. Norman, Stephen Robson, Steven Thornton, Andrew Shennan

*Corresponding author for this work

Research output: Contribution to journalArticle

22 Citations (Scopus)

Abstract

Preterm birth (PTB) is estimated to account for 6-10% of all births worldwide with 13 million PTBs occurring annually and 1 million resulting in death. The diagnosis of spontaneous preterm labor and accurate prediction of preterm delivery is notoriously difficult. Identification of effective risk assessment markers can potentially improve outcomes by enabling targeted therapy while allowing efficient use of resources and avoiding unnecessary interventions. Advances in perinatal medicine have not reduced PTB and effective measures that improve outcome are yet to be established. However, considerable progress has been made in the development of accurate methods (fetal fibronectin and cervical length assessment) to predict PTB in both symptomatic and asymptomatic high-risk women. The excellent negative predictive value of fFN has the ability to facilitate decision-making regarding admission, in utero transfer, administration of antenatal corticosteroids and/or tocolysis and has been shown to be cost-effective. This review describes the European perspective on the use of fFN and describes ongoing European clinical studies, which are appropriately designed with meaningful endpoints, which will undoubtedly facilitate a better understanding of test accuracy and cost-effectiveness within different populations.

Original languageEnglish
Pages (from-to)330-336
Number of pages7
JournalJournal of Maternal-Fetal and Neonatal Medicine
Volume24
Issue number2
DOIs
Publication statusPublished - 1 Feb 2011

Keywords

  • cost-effectiveness
  • Fetal fibronectin
  • prediction
  • spontaneous preterm birth

Fingerprint Dive into the research topics of 'Fetal fibronectin as a predictor of spontaneous preterm birth: A European perspective'. Together they form a unique fingerprint.

  • Cite this

    Chandiramani, M., Di Renzo, G. C., Gottschalk, E., Helmer, H., Henrich, W., Hoesli, I., Mol, B., Norman, J. E., Robson, S., Thornton, S., & Shennan, A. (2011). Fetal fibronectin as a predictor of spontaneous preterm birth: A European perspective. Journal of Maternal-Fetal and Neonatal Medicine, 24(2), 330-336. https://doi.org/10.3109/14767058.2010.496879